Latest Commercialization News

Echo IQ reports a remarkable 153% increase in echocardiogram processing through its EchoSolv AS platform in the US, with a Mayo Clinic validation study nearing completion ahead of a critical FDA submission. The company is also advancing European market entry and strengthening its advisory team to accelerate global growth.

Octava Minerals reports impressive bioleaching recoveries of critical minerals from its Byro project, prompting plans to acquire full ownership and expand exploration activities.

Cobalt Blue Holdings has fully repaid its $1 million promissory note to American Rare Earths, unencumbering its flagship Broken Hill Cobalt Project amid a strengthening cobalt market.

Brazilian Critical Minerals Ltd has raised A$6 million through a well-supported placement to fast-track its flagship Ema Rare Earths Project in Brazil, aiming to move closer to commercial production.

Memphasys Limited has announced a pro-rata entitlement offer to raise approximately $1.12 million, issuing new shares at $0.003 each with free attaching options, aiming to fund the commercialisation of its Felix™ system and strengthen working capital.

TG Metals Limited has reported promising metallurgical test results from its Van Uden Gold Project stockpiles, confirming high gold recoveries and favorable ore characteristics. These findings pave the way for potential toll treatment agreements and support ongoing project development.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

ImpediMed secures expanded insurance reimbursement for its SOZO platform, now covering over 301 million US lives and enhancing early detection of breast cancer-related lymphedema.

Metallium’s U.S. subsidiary has signed a pivotal Memorandum of Understanding with Glencore, setting the stage for a major supply and offtake partnership in electronic scrap recycling. This collaboration underpins Metallium’s Texas facility launch and validates its proprietary technology in a competitive market.

(E,E)-bisantrene, Race Oncology’s lead anticancer candidate, operates by binding to G4-DNA and RNA structures, revealing a novel mechanism that disrupts key cancer drivers including the MYC gene.

Excite Technology Services has shattered its previous sales record, achieving $7.14 million in contract value for September 2025, driven by strong demand in cybersecurity and digital forensics.

Intelligent Monitoring Group has acquired BNP Securities for $4.2 million, aiming to blend traditional security manpower with advanced video monitoring solutions. This move is set to boost earnings and broaden ADT Guard’s presence in Australia’s security market.